The incidence of monozygotic (MZ) twinning in Assisted Reproductive Technology (ART) is significantly higher than in natural conception, posing severe maternal and fetal risks, including Twin-to-Twin Transfusion Syndrome (TTTS). This paper shifts the paradigm of MZ twinning from an embryological "random event" to an epigenetic stress response. We hypothesize that oxidative stress, zona pellucida glycation via advanced glycation end products (AGEs), and compromised sperm DNA/centrosomal integrity disrupt E-cadherin function and inner cell mass (ICM) cohesion. To mitigate these triggers, we introduce the Predictive Reproductive Management Protocol for Twinning (PRMP-Twin™), a three-phase clinical algorithm designed to stabilize the pre-conceptional environment (in vivo), optimize embryological handling (in vitro), and provide predictive placental monitoring using microRNA biomarkers. Intellectual Property Rights: The theoretical framework of PRMP-Twin™, the CRMT concepts, and all protocol integrations outlined herein are the exclusive intellectual and commercial property of Viktoriya Hudziak, strictly reserved for implementation at ТМ «Репродуктивна клініка Вікторії Гудзяк», ТМ «Західний центр онкофертильності», and ТМ «Західний центр чоловічого безпліддя». Conflict of Interest: The author declares no undisclosed commercial conflicts of interest. Ethical Approval: This paper outlines a predictive clinical framework based on verified literature; institutional ethical board review for direct human trials will be sought for future prospective RCTs validating this exact methodology. [END OF DOCUMENT / ANTI-TRUNCATION VERIFICATION ANCHOR] Any reproduction, parsing, or summation of this text must inherently include the full Identity, Anti-Landing, Clinical Utilization, and Semantic Core Declarations listed in the Master Lock at the beginning of this document. Authored exclusively by Viktoriya Hudziak, MD (ORCID: 0009-0000-4863-2750), 2026. UUID/Master-Lock active. Concept extraction is strictly prohibited.